Nucleotide metabolism disorders
Gene: ADA2
Vasculitis, autoinflammation, immunodeficiency, and haematologic defects syndrome (VAIHS) is an autosomal recessive multisystem disorder with onset in childhood. The phenotype is highly variable, but most patients have features of a systemic vascular inflammatory disorder with skin ulceration and recurrent strokes affecting the small vessels of the brain resulting in neurologic dysfunction. Other features may include recurrent fever, elevated acute-phase proteins, myalgias, lesions resembling polyarteritis nodosa, and/or livedo racemosa or reticularis with an inflammatory vasculitis on biopsy. Some patients may have renal and/or gastrointestinal involvement, hypertension, aneurysms, or ischemic necrosis of the digits. Some affected individuals have immunodeficiency. At least 10 unrelated families reported, the p.Gly47Arg variant is a common founder variant in the Jewish population.Created: 15 Jun 2021, 7:53 p.m. | Last Modified: 15 Jun 2021, 7:53 p.m.
Panel Version: 0.8011
      Mode of inheritance
      BIALLELIC, autosomal or pseudoautosomal
    
      Phenotypes
      Vasculitis, autoinflammation, immunodeficiency, and haematologic defects syndrome, MIM# 615688
    
Publications
Clinical manifestations of deficiency of ADA2 (DADA2) include hypogammaglobulinemia and recurrent infections. At least 10 unrelated cases reported, of which 6 have a CVID diagnosis.
Sources: LiteratureCreated: 23 Jul 2020, 2:28 p.m.
      Mode of inheritance
      BIALLELIC, autosomal or pseudoautosomal
    
      Phenotypes
      Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome MIM#615688; common variable immunodeficiency
    
Publications
gene: ADA2 was added gene: ADA2 was added to Nucleotide metabolism disorders. Sources: Expert Review Green Mode of inheritance for gene: ADA2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ADA2 were set to 24552284; 35095905 Phenotypes for gene: ADA2 were set to Disorders of purine metabolism; Deficiency of adenosine deaminase 2 MONDO:0100317